NCT00479024View on ClinicalTrials.gov

Follow-up Study to Previous CARE Trial

CompletedOBSERVATIONAL
Enrollment

294

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

April 30, 2008

Conditions
Moderate to Severe Chronic Kidney Disease
Interventions
DRUG

iodinated contrast agent

iodinated contrast agent either 370 stength of iopamidol or 320 strength of visipaque

Trial Locations (1)

35209

Cardiovascular Associates, Birmingham

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY